Participants in the study comprised 91 symptomatic and 179 presymptomatic subjects with variants in the FTD genes C9orf72, GRN, or MAPT, as well as 174 mutation‐negative within‐family controls. The gene discussed is GRN; the disease is frontotemporal dementia.